NASDAQ:PSTI
Pluristem Therapeutics Inc.
- Stock
Last Close
1.03
26/07 04:00
Market Cap
40.85M
Beta: 1.91
Volume Today
170.63K
Avg: -
PE Ratio
−0.56
PFCF: −1.31
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '14 | Jun '15 | Jun '16 | Jun '17 | Jun '18 | Jun '19 | Jun '20 | Jun '21 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | |||||||||
average payables | 3.15M - | 3.37M 6.84% | 2.99M 11.29% | 2.34M 21.80% | 2.61M 11.90% | 2.77M 6.03% | 2.12M 23.33% | 2.25M 5.77% | |
average receivables | 1.13M - | 2.39M 110.83% | 2.49M 4.57% | 1.83M 26.74% | 1.01M 44.71% | 1.13M 12.22% | 1.52M 33.64% | 1.55M 2.28% | |
book value per share | 9.78 - | 8.27 15.42% | 4.80 42.02% | 3.46 27.86% | 2.69 22.19% | 1.77 34.29% | 3.08 74.24% | 2.03 34.06% | |
capex per share | -0.25 - | -0.12 52.26% | -0.22 86.07% | -0.04 80.35% | -0.03 25.29% | -0.02 40.01% | -0.01 23.44% | -0.01 10.58% | |
capex to depreciation | -0.83 - | -0.40 51.55% | -0.81 103.15% | -0.17 78.67% | -0.17 2.40% | -0.12 28.12% | -0.17 41.18% | -0.27 58.32% | |
capex to operating cash flow | 0.08 - | 0.04 50.98% | 0.09 134.27% | 0.02 81.49% | 0.02 8.55% | 0.01 49.27% | 0.01 26.18% | 0.01 17.85% | |
capex to revenue | -4.15 - | -2.19 47.17% | -0.61 71.97% | -6.84 - | -4.43 35.29% | -11.74 165.24% | |||
cash per share | 8.49 - | 7.40 12.75% | 4.05 45.32% | 2.99 26.25% | 2.82 5.43% | 1.92 31.94% | 2.52 30.90% | 2.31 8.18% | |
days of inventory on hand | |||||||||
days payables outstanding | 114.97K - | 91.76K 20.20% | 9.87K 89.24% | 595.13K - | 416.28K 30.05% | ||||
days sales outstanding | 2.18K - | 2.42K 10.83% | 318.08 86.83% | 6.18K - | 9.60K 55.34% | 25.55K 166.01% | |||
debt to assets | 0.16 - | 0.15 8.62% | 0.17 15.35% | 0.19 14.51% | 0.27 38.27% | 0.30 12.96% | 0.14 52.51% | 0.39 170.30% | |
debt to equity | 0.19 - | 0.17 10.11% | 0.20 18.49% | 0.24 18.00% | 0.37 52.31% | 0.43 18.59% | 0.17 61.34% | 0.64 278.73% | |
dividend yield | |||||||||
earnings yield | -0.14 - | -0.14 2.52% | -0.22 57.70% | -0.25 13.12% | -0.20 18.62% | -0.49 139.90% | -0.18 62.65% | -0.45 147.16% | |
enterprise value | 193.67M - | 154.49M 20.23% | 99.58M 35.55% | 107.20M 7.66% | 120.35M 12.27% | 68.66M 42.95% | 154.18M 124.56% | 104.67M 32.11% | |
enterprise value over ebitda | -7.74 - | -6.83 11.67% | -4.72 30.94% | -4.18 11.41% | -4.99 19.39% | -2.06 58.75% | -5.63 173.42% | -2.16 61.60% | |
ev to operating cash flow | -10.13 - | -7.50 25.98% | -5.38 28.30% | -4.96 7.73% | -5.63 13.48% | -2.33 58.59% | -5.85 150.82% | -3.39 42.08% | |
ev to sales | 511.01 - | 407.63 20.23% | 34.98 91.42% | 2.41K - | 1.27K 47.18% | 6.70K 427.23% | |||
free cash flow per share | -3.26 - | -3.05 6.39% | -2.55 16.44% | -2.52 1.30% | -2.05 18.43% | -2.41 17.35% | -1.46 39.20% | -1.11 23.99% | |
free cash flow yield | -0.10 - | -0.12 15.90% | -0.19 58.32% | -0.20 2.55% | -0.17 14.42% | -0.41 142.65% | -0.17 59.42% | -0.28 69.68% | |
graham net net | 6.88 - | 6.25 9.20% | 3.30 47.11% | 2.25 31.79% | 1.90 15.84% | 1.24 34.67% | 2.06 66.58% | 1.06 48.85% | |
graham number | 30.55 - | 25.56 16.31% | 17.76 30.53% | 15.74 11.38% | 12.23 22.31% | 10.68 12.68% | 10.54 1.26% | 9.01 14.56% | |
income quality | 0.71 - | 0.83 17.61% | 0.80 4.58% | 0.78 2.48% | 0.82 5.32% | 0.83 1.94% | 0.90 8.43% | 0.62 31.47% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -150.39 - | -649.01 331.56% | |||||||
interest debt per share | 0.01 - | 0.88 8,044.46% | |||||||
inventory turnover | |||||||||
invested capital | 0.43 - | ||||||||
market cap | 198.16M - | 177.12M 10.62% | 105.80M 40.27% | 111.91M 5.77% | 129.17M 15.43% | 72.76M 43.67% | 160.86M 121.08% | 111.33M 30.79% | |
net current asset value | 50.09M - | 46.86M 6.45% | 27.81M 40.65% | 21.73M 21.85% | 21.58M 0.69% | 16.88M 21.78% | 39.03M 131.19% | 30.98M 20.61% | |
net debt to ebitda | 0.18 - | 1.00 457.66% | 0.29 70.53% | 0.18 37.76% | 0.37 99.29% | 0.12 66.35% | 0.24 98.24% | 0.14 43.67% | |
net income per share | -4.24 - | -3.51 17.20% | -2.92 16.77% | -3.18 8.87% | -2.47 22.44% | -2.86 16.02% | -1.60 44.04% | -1.77 10.72% | |
operating cash flow per share | -3.01 - | -2.93 2.62% | -2.33 20.58% | -2.47 6.16% | -2.02 18.31% | -2.39 18.27% | -1.45 39.32% | -1.10 24.13% | |
payables turnover | 0.00 - | 0.00 25.31% | 0.04 829.33% | 0.00 - | 0.00 42.96% | ||||
receivables turnover | 0.17 - | 0.15 9.77% | 1.15 659.36% | 0.06 - | 0.04 35.63% | 0.01 62.41% | |||
research and ddevelopement to revenue | 51.56 - | 50.59 1.89% | 6.88 86.41% | 452.58 - | 489.39 8.13% | 938.13 91.69% | |||
return on tangible assets | -0.36 - | -0.36 0.48% | -0.51 39.75% | -0.74 46.45% | -0.67 9.51% | -1.13 68.16% | -0.44 60.55% | -0.53 19.84% | |
revenue per share | 0.06 - | 0.05 9.63% | 0.36 563.71% | 0.00 - | 0.00 7.28% | 0.00 71.13% | |||
roe | -0.43 - | -0.42 2.10% | -0.61 43.55% | -0.92 50.92% | -0.92 0.32% | -1.62 76.55% | -0.52 67.88% | -0.87 67.91% | |
roic | -0.45 - | -1.29 184.50% | -0.76 41.15% | -1.07 41.45% | -1.87 74.37% | -1.71 8.63% | -0.63 63.28% | -1.77 183.07% | |
sales general and administrative to revenue | 22.89 - | 17.04 25.54% | 2.28 86.63% | 223.86 - | 169.57 24.25% | 344.43 103.12% | |||
shareholders equity per share | 9.78 - | 8.27 15.42% | 4.80 42.02% | 3.46 27.86% | 2.69 22.19% | 1.77 34.29% | 3.08 74.24% | 2.03 34.06% | |
stock based compensation to revenue | 15.44 - | 10.69 30.75% | 1.08 89.90% | 130.96 - | 95.30 27.23% | 111.39 16.89% | |||
tangible asset value | 62.12M - | 58.14M 6.41% | 38.16M 34.38% | 30.25M 20.72% | 28.51M 5.77% | 21.82M 23.45% | 56.10M 157.10% | 57.15M 1.87% | |
tangible book value per share | 9.78 - | 8.27 15.42% | 4.80 42.02% | 3.46 27.86% | 2.69 22.19% | 1.77 34.29% | 3.08 74.24% | 2.03 34.06% | |
working capital | 54.59M - | 50.69M 7.15% | 29.82M 41.16% | 23.60M 20.85% | 23.49M 0.48% | 18.21M 22.46% | 40.47M 122.23% | 55.85M 38.00% |
All numbers in USD (except ratios and percentages)